FRANCE-HEALTH-OBESITY
This photograph shows a KwikPen of the drug Mounjaro, containing the active ingredient tirzepatide, used in the treatment of obesity, at the Valenciennes Hospital Centre (Centre Hospitalier de Valenciennes) in Valenciennes, northern France on June 12, 2026. Virginie hopes she's on the brink of "a life change": starting on June 15, 2026, many patients like her will be able to access Mounjaro and Wegovy, two anti-obesity medications that are now reimbursed, and requests are already pouring in at the specialized center in Valenciennes, northern France. (Photo by Sameer Al-DOUMY / AFP via Getty Images)
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesFRANCE-HEALTH-OBESITY, News Photo
FRANCE-HEALTH-OBESITY Get premium, high resolution news photos at Getty ImagesProduct #:2280584120
FRANCE-HEALTH-OBESITY Get premium, high resolution news photos at Getty ImagesProduct #:2280584120$499$175
Getty Images
In stockDETAILS
Credit: SAMEER AL-DOUMY / Contributor
Getty Images editorial coverage is captured by expert trusted visual journalists. Learn more about our editorial policies.
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.TO GO WITH AFP STORY by Anne ROLANDIN
Editorial #:
2280584120
Collection:
AFP
Date created:
June 12, 2026
Upload date:
License type:
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_B6WY9T3
Max file size:
4362 x 2908 px (14.54 x 9.69 in) - 300 dpi - 4 MB